Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial

Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:24:09.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about the X-TOLE3 Phase 3 clinical trial for XEN1101, which included eligibility criteria and study design, while adding a new revision number and collaborators.
    Difference
    21%
    Check dated 2025-04-16T20:36:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now indicates that the study has increased from 65 to 66 locations, and it includes a new location in Brussels, Belgium. Additionally, the revision number has been updated from v2.14.3 to v2.14.4.
    Difference
    1%
    Check dated 2025-04-09T14:50:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date (2025-03-25).
    Difference
    0.2%
    Check dated 2025-04-02T00:18:28.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now lists 65 study locations, including new sites in Belgium, Germany, and Italy, and updates the trial date to 2025-03-03. The previous date of 2025-02-06 and the count of 62 locations have been removed.
    Difference
    2%
    Check dated 2025-03-04T04:24:57.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:09:48.000Z thumbnail image

Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.